|Articles|July 7, 2022 (Updated: September 22, 2022)

Pharmaceutical Executive

  • Pharmaceutical Executive-07-01-2022
  • Volume 42
  • Issue 7

Pharmaceutical Executive, July 2022 Issue (PDF)

Click the title above for a link to open the Pharmaceutical Executive July 2022 issue in an interactive PDF format.

Click cover to access PDF

Articles in this issue

over 3 years ago

The True Nature of Danger Behind IP Waiver Proposal

over 3 years ago

In DOJ Crosshairs: Rethinking Commission-Based Deals With Independent Contractors

over 3 years ago

Cracking Down on Speaker Programs

over 3 years ago

Dynamic Compliance: The Best Defense for Pharma

over 3 years ago

A Steadying Force in C-Suite: The Changing Role of Biopharma CFOs

over 3 years ago

Breaking Down Barriers

over 3 years ago

Biotech Performance Glance—and Promising Ripples for Recovery

over 3 years ago

If Non-Formulary Hospital, Price May Not Be the Rx

over 3 years ago

When It Comes To DE&I, Silence Is Deafening

over 3 years ago

Asia’s Rise in The Global Pharma Industry

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!